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Am J Physiol Lung Cell Mol Physiol 287: L835–L842, 2004. First
published June 18, 2004; 10.1152/ajplung.00285.2003.—Extracellu-
lar purines and pyrimidines regulate various physiological responses
via the cell surface receptors known as purinoreceptors and may exert
autocrine or paracrine effects on ion transport, fluid transport, ciliary
beat frequency, and mucin secretion. Therefore, this study aims to
investigate the expression patterns of the purinoreceptors in normal
human nasal epithelial (NHNE) cells. In RT-PCR, the mRNAs for
several P2X (P2X3, P2X4, P2X7) and P2Y (P2Y1, P2Y2, P2Y4, P2Y6,
P2Y11, P2Y12) receptors were identified in NHNE cells. Functional
localizations of P2 receptors were investigated by measuring intracel-
lular calcium concentration ([Ca2]i) increases in membrane-specific
manner using a double-perfusion chamber. Absence of the responses
of -methylene ATP and 2-methylthio-ATP excluded functionally
active P2X3, P2X4, and P2Y1 receptors as far as [Ca2]i increase is
concerned. Applications with ATP and UTP revealed that luminal
membranes of NHNE cells express P2Y2 and P2Y6 receptors and
basolateral membranes express P2Y2 receptor. Expressions of P2Y2
and P2Y6 receptors in NHNE cells were further verified by immuno-
blotting using specific antibodies. In addition, the results with 2,3-O-
(4-benzoyl)-benzoyl-ATP indicate that the P2Y11 receptor may be
present on the luminal side. In conclusion, the NHNE cells express
functionally active P2Y2, P2Y6, and P2Y11 receptors in a membrane-
specific pattern, which may play an important role in the control of
mucin and fluid secretion in NHNE cells.
purinoreceptor; calcium; secretion
THE NASAL EPITHELIUM actively secretes most of the mucus and
determines the electrolyte composition of nasal secretions.
Nasal hypersecretion is a common feature in various nasal and
paranasal sinus diseases such as rhinitis and sinusitis. In
general, nasal secretion results from stimulation of secreta-
gogues and inflammatory mediators (29). Secretagogues stim-
ulate the release of the serous and mucous components inside
cells as an early event of secretion before the activation of the
secretory genes. Representatives of the secretagogues are the
extracellular triphosphate nucleotides. The extracellular pu-
rines (adenosine, ADP, and ATP) and pyrimidines (UDP,
UTP) regulate the various physiological responses via the cell
surface receptors termed purinoreceptors and exert autocrine or
paracrine effects on ion transport (1, 2, 15), fluid transport (1,
2), ciliary beat frequency (15, 18), and mucin secretion (10,
12). Thus the purinoreceptors in nasal epithelial cells may play
an important role in the early stages of secretion under inflam-
matory conditions.
Up to now, nine G protein-coupled (P1, P2Y) and eight
ligand-gated (P2X) purinoreceptors have been identified in
mammalian cells (8, 21). ATP and UTP regulate the cellular
processes via interactions with the cell-surface ion-gated (P2X)
and G protein-coupled (P2Y) receptors. ATP is an effective
agonist of the P2Y2 and P2Y11 receptors, whereas UTP acti-
vates the P2Y2 and P2Y4 receptors (18). Certain P2Y receptors
are activated principally by nucleoside diphosphate. For exam-
ple, ADP activates the P2Y1 receptor, and UDP activates the
P2Y6 receptor (18).
Until recently many investigations have been carried out to
characterize the P2 receptors that are expressed in various
kinds of cells and tissues including submandibular acinar cells
(14) and pancreatic duct cells (16). However, there are only a
few reports on the expression of the purinoreceptors in nasal
epithelial cells (13). Because most of those studies were based
only on a pharmacological approach for determining the po-
tency of their agonists and/or antagonists, the characterization
of the P2 receptors in the airway epithelial cells has not been
fully clarified. Therefore, the aims of this study were, first, to
investigate which mRNAs and proteins of the P2X and P2Y
receptors are expressed in normal human nasal epithelial
(NHNE) cells using RT-PCR and Western blot analysis and,
second, to examine which of the P2X and P2Y receptor
subtypes are functionally active on the intracellular calcium
levels using various agonists and antagonists.
MATERIALS AND METHODS
Chemicals and solutions. Fura-2-AM was purchased from Molec-
ular Probes (Eugene, OR), and pyridoxal phosphate-6-azophenyl-
2,4-disulfonic acid (PPADS) was obtained from Tocris Cooksom
(Bristol, UK). All other chemicals, including ATP, UTP, UDP,
2-methylthioadenosine 5-triphosphate (2MeS-ATP), 2,3-O-(4-ben-
zoyl)-benzoyl-ATP (BzATP), -methylene ATP (-Me ATP), and
caffeine, were purchased from Sigma. The standard perfusion solution
(luminal and basolateral) contained 140 mM NaCl, 5 mM KCl, 1 mM
MgCl2, 1 mM CaCl2, 10 mM D-glucose, and 10 mM HEPES (pH 7.4
with NaOH).
Cell culture and specimen preparation. Passage 2 NHNE cells
were prepared as previously described (28). The Ethics Committee of
Yonsei University College of Medicine approved all the procedures
used in this study. The passage 2 NHNE cells (5.0  104 cells) were
plated on a Transwell clear (Costar, Cambridge, MA) culture insert
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with a 0.45-m pore size. The cells were cultured in a 1:1 mixture of
bronchial epithelium growth medium/DMEM containing various sup-
plements until confluence. After confluence was achieved, the func-
tionally polarized monolayers of the NHNE cells were loaded with
fura-2 (5 M at 37°C for 25 min) before being mounted in a miniature
Ussing chamber attached to the stage of the objective microscope.
RT-PCR for receptor subtypes of P2X and P2Y. RT-PCR was used
to detect the expression of the mRNAs for human P2X (P2X1, P2X2,
P2X3, P2X4, P2X6, P2X7, P2XM) and P2Y receptor subtypes (P2Y1,
P2Y2, P2Y4, P2Y6, P2Y11, P2Y12). The oligonucleotide primers were
designed for the mRNA of each gene product using Gene Runner
software version 3.00 and the previously published sequences. The
oligonucleotide amplimers for 2-microglobulin (2M) for control
PCR reaction, purchased from Clontech Laboratories (Palo Alto, CA),
generated a 335-bp PCR fragment. The RT-PCRs were performed
using a Perkin Elmer Cetus DNA Thermal Cycler according to the
manufacturer’s protocol. The total RNA (1 g per 20-l reaction
volume) was reverse-transcribed into complementary DNA (cDNA)
with the random hexanucleotide primers and Moloney murine leuke-
mia virus reverse transcriptase. Negative controls were obtained by
omitting the reverse transcriptase from the RT reaction to verify that
the amplified products were from the mRNA and not from the
genomic DNA contamination. No PCR products were observed in the
absence of reverse transcriptase. Specific amplifications of the P2
receptor mRNAs were confirmed by sequencing (dsDNA Cycle Se-
quencing System; GIBCO-BRL, Gaithersburg, MD) of the PCR
fragments. Forty percent for each P2 receptor or 4% for 2M of the
resulting cDNA was amplified with 0.2 nmol/l of each primer. The
optimized concentration of MgCl2 in the PCR was 1.5 mmol/l for P2X
and P2Y receptors. Human embryonic kidney-293 cells were used as
positive controls for the P2X3 and P2X4 receptors. Human skeletal
muscle cells were used as positive controls for P2XM. Human platelet
cells were used as positive controls for P2Y12. Normal human brain
cells were used as positive controls for the remaining receptors tested.
The oligonucleotide primers designed for the purinoreceptors used in
this experiment and their reaction conditions are listed in Tables 1
and 2.
Measurement of [Ca2]. The measurements of the [Ca2] in the
monolayers were performed based on the previously reported proto-
cols with a slight modification (11, 19). After reaching confluence, the
cells were loaded with fura-2 by incubating (30 min, 37°C) them in
medium containing 3 M fura-2-AM. The membranes bearing the
fura-2-loaded NHNE cells were mounted in a miniature Ussing
chamber (AKI Institute, University of Copenhagen, Copenhagen,
Denmark) attached to the stage of an inverted microscope. The
chamber is consisted of top (luminal) and bottom (basolateral) half-
chambers (volume  250 l each) made from light-absorbing poly-
acetal. The membrane containing the polarized epithelial monolayer
was located in between the two half-chambers, separating the chamber
into a luminal (upper) and a basolateral (lower) compartment. Effec-
tive sealing was achieved using rubber O-rings embedded in the
grooves of the two half-chambers, which were screwed tightly to-
gether. A transparent coverslip was placed at the bottom of the
perfusion chamber, which allowed fluorescence measurements from
the dye-loaded monolayers using objective lenses having a long
working distance (2 mm). The luminal chamber was open to the
atmosphere. Both half-chambers had inlet and outlet ports to allow the
solution to flow. The luminal and basolateral perfusates were heated
to 37°C and delivered to the chamber by gravity flow (rate  3–5
ml/min). The fura-2 fluorescence ratio was recorded (PTI Delta Ram,
Photon Technology International) from an area in the center of the
epithelium. The fura-2 fluorescence was recorded at excitation wave-
lengths of 350 and 380 nm, and the results are expressed as the
350/380 fluorescence ratio.
Immunoblot analyses for P2Y2 and P2Y6 receptors. NHNE cells
were lysed with 2 sample buffer [250 mM Tris Cl (pH 6.5), 2%
SDS, 4% 2-mercaptoethanol, 0.02% bromphenol blue, and 10%
glycerol]. Equal amounts of whole cell lysates were resolved by 10%
SDS-PAGE and transferred to a polyvinylidene difluoride membrane
(Millipore, Bedford, MA). Membranes were blocked with 5% skim
milk in Tris-buffered saline [TBS, 50 mM Tris Cl (pH 7.5), 150 mM
NaCl] for 2 h at room temperature. This blot was then incubated
overnight with primary antibody (P2Y2, P2Y6, 1:500; Alomone Labs,
Jerusalem, Israel) in TTBS (0.5% Tween 20 in TBS). Negative control
experiment with the control peptide (preincubation with the same
amount of antibody for 1 h at room temperature) used for immuniza-
tion was done to check specificity of the primary antibody. After
washing the blot with TTBS, we further incubated the blot for 45 min
at room temperature with anti-goat antibody (1:2,000; Vector Labo-
ratories, Burlingame, CA) in TTBS and then visualized it by using the
ECL system (Amersham-Pharmacia, Piscataway, NJ). The same ex-
periments were repeated three times with nearly identical results.
Table 1. RT-PCR primers and the reaction conditions for the P2X receptors
Primers GenBank No. Reaction Conditions, °C/30 s Expected Size, bp
P2X1 94
Sense: CTGGCTGAGAAGGGTGGAGTGGTTGG AF020498 65 392
Anti: TGGCCCCATGTCCTCAGCGTATTTG 72
P2X2 94
Sense: GCTGCTCATCCTGCTCTACTTCGTGTGG NM016318 65 399
Anti: GGGGTAGTGGATGCTGTTCTTGATGAGG 72
P2X3 94
Sense: ATCAACCGAGTAGTTCAGC Y07683 50 695
Anti: GATGCACTGGTCCCAGG 72
P2X4 94
Sense: GAGATTCCAGATGCGACC U83993 50 296
Anti: GACTTGAGGTAAGTAGTGG 72
P2X6 94
Sense: AGTTCAACTTCTCTAAGTCCAATGC AF065385 50 470
Anti: CTCTATCCACATACAGCAGTAGC 72
P2X7 94
Sense: CCCCGGCCACAACTACACCACGAGAAAC NM002562 67 440
Anti: CCGAAGTAGGAGAGGGTTGAGCCGATG 72
P2XM 94
Sense: GCTTGGCTGGGCGTGGTCACCTTTTTCTG AB002058 67 332
Anti: CCCGCCCTTCCCAGCCCCCAACTCTC 72
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RESULTS
P2 receptor mRNA expressions by RT-PCR. The expression
pattern of the mRNA transcripts for the P2X and P2Y receptors
in NHNE cells was investigated, as has been previously re-
ported for certain subtypes of the P2 receptors in different
human epithelial cells (18). As shown in Fig. 1A, only the
P2X3, P2X4, and P2X7 receptor mRNAs were expressed
among the seven subtypes of the P2X receptors tested (Fig.
1A). In addition, the mRNAs for the P2Y1, P2Y2, P2Y4, P2Y6,
P2Y11, and P2Y12 receptors were identified in NHNE cells
(Fig. 1B). However, it is still unclear whether or not all these
mRNAs for the P2 receptors expressed in the NHNE cells are
functionally active in terms of the intracellular calcium re-
sponse.
Presence of P2X and P2Y receptors in luminal and baso-
lateral membranes of nasal epithelial cells. Three different
concentrations of ATP, a P2 receptor agonist, were used to
determine whether P2 receptors are located in the luminal or
basolateral membrane of the NHNE cells. The intracellular
calcium level in response to luminal or basolateral ATP ad-
ministration was increased to a similar level (Fig. 2, A and B).
However, the intracellular calcium level in response to luminal
ATP administration was slightly higher than the level in
response to basolateral ATP administration at lower ATP
concentrations (1 and 10 M).
We next investigated whether the P2X and P2Y receptors
are located in the luminal or basolateral side by use of their
functional antagonists. When the cells were pretreated with 40
mM caffeine, which blocks the intracellular calcium concen-
tration ([Ca2]i) response of metabotropic P2Y receptors by
inhibiting inositol 1,4,5-trisphosphate receptors, the intracellu-
lar calcium levels in response to luminal or basolateral ATP
administration abruptly decreased (Fig. 2, C and D). When the
cells were pretreated with 10 M PPADS, a nonspecific
antagonist of ionotropic P2X receptors, the intracellular cal-
cium levels in response to luminal or basolateral ATP admin-
istration were not altered (Fig. 2, E and F). These results
suggest that NHNE cells have functionally active P2Y recep-
tors, but not P2X receptors, in luminal and basolateral mem-
branes.
Agonists that do not evoke [Ca2]i response. The roles of
the functional P2X and P2Y1 receptors were examined using
more selective agonists for P2 receptors in the luminal and
basolateral sides of the NHNE cells. Interestingly, applications
of -Me ATP (Fig. 3, A and B) or 2MeS-ATP (Fig. 3, C and
D) did not evoke any [Ca2]i response in NHNE cells. -Me
ATP and 2MeS-ATP can activate P2X3, P2X4, and P2Y1
receptors (7) among the P2 receptors identified by RT-PCR
analysis in NHNE cells.
Effects of P2Y receptor agonists. Because the activation of
most P2Y receptors increases the intracellular calcium level,
the presence and cellular localization of the P2Y receptors can
be partially determined by measuring the effects of the P2Y
receptor agonists on the intracellular calcium level. This study
analyzed the response in the luminal and basolateral sides of
the NHNE cells to UTP (P2Y2, P2Y4, and P2Y6 agonist) and
UDP (P2Y6 agonist) (20). When the luminal or basolateral side
of the cells was treated with UTP, the [Ca2]i was increased to
a similar level as with ATP (Fig. 4, A and B). Interestingly,
basolateral application of UDP (10 M) did not evoke [Ca2]i
signals (Fig. 4B), whereas luminal application of the same
Table 2. RT-PCR primers and the reaction conditions for the P2Y receptors
Primers GenBank No. Reaction Conditions, °C/30 s Expected Size, bp
P2Y1 94
Sense: CCCTGGGCCGGCCTCAAAAAGAAGAATG NM002563 65 389
Anti: CAAGCCGGGCCCTCAAGTTCATCGTTTTC 72
P2Y2 94
Sense: GCTACAGGTGCCGCTTCAACGAGGACTTC NM002564 65 428
Anti: GGCAGGCCAGCACCAACACCCACAC 72
P2Y3 94
Sense: CCACCTGGCATTGTCAGACACC X91852 63 424
Anti: GAGTGACCAGGCAGGGCACGC 72
P2Y6 94
Sense: CCCTGCTGGCCTGCTACTGTCTCCTG U52464 62 455
Anti: CTAATTCTCCGCATGGTTTGGGGTTGG 72
P2Y11 94
Sense: CCCCCGCTGGCCGCCTACCTCTATCC AF030335 67 396
Anti: CGCAGCCCAACCCCGCCAGCACCAG 72
P2Y12 94
Sense: CTAAGATTCTCTCTGTTGTCATCTG AF313449 50 432
Anti: ACAGAGTGCTCTCTTTCACATAG 72
Fig. 1. P2 receptor mRNA expression with RT-PCR. The mRNAs for P2X3,
P2X4, P2X7 (A), P2Y1, P2Y2, P2Y4, P2Y6, P2Y11, and P2Y12 receptors (B)
were expressed in normal human nasal epithelial (NHNE) cells.
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Fig. 2. Presence of functionally active P2Y receptors in NHNE cells. Three different ATP concentration (1, 10, 100 M)
successfully increased the intracellular calcium levels on both the luminal and basolateral sides (A, B), indicating the presence of
the P2 receptors on both sides of the NHNE cells. The higher intracellular calcium induced by 100 M ATP was successfully
blocked by 40 mM caffeine on both sides of the NHNE cells (C, D), indicating the presence of the P2Y receptors. In contrast, 10
M of pyridoxal phosphate-6-azophenyl-2,4-disulfonic acid (PPADS) could not block the increased intracellular calcium level
induced by 100 M ATP on both sides of the NHNE cells (E, F), which indicates the absence of functionally active P2X receptors.
L838 PURINERGIC RECEPTORS IN HUMAN NASAL EPITHELIA
AJP-Lung Cell Mol Physiol • VOL 287 • OCTOBER 2004 • www.ajplung.org
concentration of UDP significantly increased [Ca2]i in NHNE
cells (Fig. 4A).
Next, the response to 100 M of BzATP, which can activate
P2X7 and P2Y11 receptors (27), was investigated in the luminal
or basolateral sides of NHNE cells. The intracellular calcium
level in response to the administration of BzATP was increased
only on the luminal side, not on the basolateral side (Fig. 4C).
Furthermore, pretreatment with caffeine abolished 80% of
the BzATP-induced [Ca2]i response (Fig. 4D), which sug-
gests that the P2Y11 rather than the P2X7 receptor is respon-
sible for the BzATP-induced effects.
Immunoblot analyses for P2 receptors in NHNE cells. The
presence of proteins for P2Y2 and P2Y6 receptors, which
revealed functionally active purinoreceptors, was investigated
by Western blotting (Fig. 5). For the P2Y2 receptor, a band of
	35 kDa, compatible with the deduced protein size, was
observed. In addition, extra bands 	55 and 120 kDa were
found in the immunoblot of P2Y2, which were also reported in
previous studies (4, 23, 26). In a recent report, it was suggested
that the multiple bands of P2Y2 receptors could be the results
of posttranscriptional modification of protein, oligomerization
of receptor, or formation of heteromers with other proteins
(26). In the immunoblot of P2Y6, a clear band of 	42 kDa,
compatible with the deduced size of P2Y6, and a faint band
	68 kDa were observed similar to a previous report (26).
Importantly, the specificities of P2Y2 and P2Y6 immunoblots
were verified with relevant peptide antigens (Fig. 5, right).
DISCUSSION
Mucus secretion is closely related to the intracellular cal-
cium level (3, 9, 25). The secretagogues induce the exocytosis
of the preformed secretory granules usually within 5–10 min
after stimulation (3). On the other hand, it takes at least 8–12
Fig. 3. Agonists that do not evoke calcium signals. Stimulation of both sides of the NHNE cells with 10 M of -methylene ATP
(-Me ATP) showed no changes in the intracellular calcium level (A, B). Similar responses were observed when the
2-methylthioadenosine 5-triphosphate (2MeS-ATP) was added on both sides of the NHNE cells (C, D).
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h to induce exocytosis of the newly formed secretory granules
made by the inflammatory mediators (25). Accordingly, it is
possible that there are two secretory patterns. Secretagogues
induce the early stages of secretion, and the inflammatory
mediators induce the late stages. In the present study we
examined the effects of the purinoreceptor agonists, which are
the potent secretagogues, on the intracellular calcium level,
since calcium signals are involved in the control of epithelial
fluid and ion secretion as well as mucus secretion (9). For
example, recently we have shown that purinergic stimulation
contributes to the Cl
-driven fluid secretion by activating
Na,K,2Cl
 cotransporter in the basolateral membrane of
NHNE cells (24).
In the present study, the expression patterns of the P2
receptor subtypes were analyzed in NHNE cells first by
RT-PCR. Previous studies have shown that epithelial cells
express multiple P2 receptor subtypes such as in pancreatic
duct cells (16), human keratinocytes (7), and rat lens epi-
thelial cells (17). In addition, cell lines originated from
airway epithelia, such as 1HAEo-, 16HBE14o-, and A549
cells, have been reported to express the mRNAs for the
P2Y2, P2Y4, and P2Y6 receptors, but not for the P2Y1 or
P2Y11 receptors (5). These results imply that the expression
patterns can differ among the epithelial cells of various
organs, and even between epithelial cells from the upper and
lower airways.
Fig. 4. Effects of the P2Y receptor agonists. Both sides of the NHNE cells were stimulated with 10 M of UTP (agonist for P2Y2
and P2Y4 receptors) and UDP (agonist for P2Y6 receptors) along with 10 M of ATP for the control. The intracellular calcium
levels were elevated to a similar level for both UTP and UDP in the luminal side (A), but UDP did not elevate the intracellular
calcium level in the basolateral side of the NHNE cells (B). These results suggest that the P2Y2 receptor is present in both the
luminal and basolateral side of the NHNE cells, but the P2Y6 receptor is present only in the luminal side of the NHNE cells.
Stimulating the NHNE cells with 100 M 2,3-O-(4-benzoyl)-benzoyl-ATP (BzATP) resulted in an increased intracellular calcium
level only on the luminal side of the NHNE cells (C), which was successfully blocked by pretreatment with 40 mM caffeine (D).
This indicates that a certain type of P2Y receptor is present only on the luminal side of the NHNE cell, most likely the P2Y11
receptor.
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Although we initially investigated the P2R expression pat-
terns using RT-PCR, the technique has significant limitations.
RT-PCR does not generate quantitative data and can detect a
very small amount of messages that do not perform a signifi-
cant role in the cells. For that reason, expression patterns of
functionally active P2Rs and their membrane-specific localiza-
tions were further examined using [Ca2]i measurements. The
results suggest that the P2 receptors are present on both the
luminal and basolateral sides of the NHNE cells. Moreover, it
was shown that functionally active P2Y receptors were present
on both the luminal and basolateral sides of the NHNE cells by
blocking the effect of ATP with caffeine. However, in this
study, PPADS did not inhibit the ATP-induced increase in
intracellular calcium level, which suggests that there are no
functionally detectable P2X receptors in the luminal or baso-
lateral side of the NHNE cells, although the P2X3, P2X4, and
P2X7 receptor mRNAs were identified in the RT-PCR. This
indicates that either the functional P2X receptor is not present
in the NHNE cells or the function of the P2X receptor may be
extremely weak as far as [Ca2]i increase is concerned.
This study also examined the effects of various purinergic
agonists in the luminal and basolateral membranes of NHNE
cells (Fig. 3). Difficulties in determining with certainty which
of the P2Y receptors are functional in human nasal epithelial
cells begin with the cross-reactivity of most P2 receptor ago-
nists with various P2Y receptors. Nevertheless, the P2Y1
receptor is quite sensitive to stimulation by 2MeS-ATP, and
the potency of this agonist to increase intracellular calcium
level is high (5). Even after the cells were treated with 10 M
2MeS-ATP, there was also no change in the intracellular
calcium level in response either to luminal or to basolateral
2MeS-ATP administration (Fig. 3B). This suggests that the
P2Y1 receptor is not active in NHNE cells.
The intracellular calcium level increased significantly in
response to luminal ATP, UTP, and UDP administration (Fig.
4A). However, when the same agonists were applied to the
basolateral side, the intracellular calcium level was increased
only in response to ATP and UTP, but not to UDP (Fig. 4B).
ATP is an effective agonist of the P2Y2 and P2Y11 receptors,
UTP is an agonist for the P2Y2 and P2Y4 receptors, and UDP
is an agonist for the P2Y6 receptors (18, 22). Generally, P2Y4
receptor responds to UTP much more sensitively than to ATP
(22). In an experiment measuring the potencies for [Ca2]i
increase, ED50 of UTP (luminal 2.8  1.2 M, basolateral
19  4 M) did not show significant difference from that of
ATP (luminal 2.3  0.9 M, basolateral 23  5 M). The
equal potency of ATP and UTP in the luminal and basolateral
membranes implies that the P2Y4 receptor is not the predom-
inant P2Y receptor in NHNE cells. Because UDP evoked
calcium signals only on the luminal side, it was concluded that
the luminal membrane of NHNE cells expresses the P2Y6
receptor. Therefore, the above results suggest that both P2Y2
and P2Y6 receptors are present on the luminal side, but only
the P2Y2 receptor is present on the basolateral side of NHNE
cells. In addition, immunoblotting using specific antibodies and
the relevant blocking peptides demonstrated the expression of
P2Y2 and P2Y6 receptor proteins in NHNE cells (Fig. 5).
Lastly, to identify the presence of P2Y11 receptors, the
response to 100 M BzATP in the luminal or basolateral
membranes of human nasal epithelial cells was analyzed, since
BzATP at 100 M concentration acts as a P2Y11-selective
agonist (6). The intracellular calcium level increased in re-
sponse to BzATP administration only to the luminal mem-
brane, but not to the basolateral (Fig. 4C). The effect of luminal
BzATP administration was successfully blocked when the cells
were pretreated with caffeine, which excluded the possibility
of P2X7 activation (Fig. 4D). This suggests that the P2Y11
receptor may be present and active only in the luminal mem-
brane of the NHNE cells.
In summary, we found functionally active P2Y2, P2Y6, and
P2Y11 receptors in the luminal membrane and the P2Y2 recep-
tor in the basolateral membrane of the NHNE cells, which may
play an important role in controlling the mucus and fluid
secretion. In addition, NHNE cells do not appear to have
functional P2X receptors to evoke significant [Ca2]i signals.
Future studies using P2 receptor subtype-specific agonists
and/or antagonists will elucidate the precise role of each P2
receptor on the secretory mechanisms in NHNE cells.
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Fig. 5. Immunoblotting of P2Y2 and P2Y6 receptor subtype in NHNE cells. In
the immunoblot of P2Y2, a band 	35 kDa, compatible with the deduced
protein size, was observed. In addition, extra bands 	55 and 120 kDa were
found in the immunoblot of P2Y2. However, when the anti-P2Y2 antibody was
preincubated with control peptide antigen, no band was found (A). In the
immunoblot of P2Y6, a clear band 	42 kDa, compatible with the deduced size
of P2Y6, and a faint band 	68 kDa were observed. However, when the
anti-P2Y6 antibody was preincubated with control peptide antigen, no band
was found (B).
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